News & Perspective

Jan 18, 2019

Jan 18, 2019

ASP Scan (Weekly) for Jan 18, 2019

New CARB-X funding
VRE in Swiss hospitals
Antibiotic overprescribing in tots
Fast track for new C diff drug
Stewardship in pediatric surgery
MRSA decline in Germany
Antibiotic resistance on pig farms
Resistance genes in Bolivian river
Stewardship in English hospitals
Whiff of C diff in pets
Fecal microbiota transplant trial

Jan 14, 2019

Jan 14, 2019

Stewardship / Resistance Scan for Jan 14, 2019

Stewardship in English hospitals
Whiff of C diff in pets
Fecal microbiota transplant trial

Jun 30, 2017

Jun 30, 2017

ASP Scan (Weekly) for Jun 30, 2017

Students' antibiotic knowledge
MCR-1 in Portugal
Opposition to AMR budget cuts
Antibiotics for skin wounds
Antibiotic resistance at the Hajj
C diff in cancer patients
Contact precautions for MRSA
Antibiotic-resistant acne

Oct 18, 2011

Oct 18, 2011

Anthrax countermeasures better than in 2001, but work remains

(CIDRAP News) – If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.

Apr 29, 2009

Apr 29, 2009

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Dec 14, 2004

Dec 14, 2004

Shortage spurs trial of GlaxoSmithKline flu vaccine

As part of efforts to improve the nation's long-term supply of influenza vaccine, the federal government is launching a clinical trial to help get a German-made vaccine licensed for regular use in the United States.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»